Losartan Recall Expanded by FDA Over Cancer Concerns

FDA Alerts

Losartan Lawsuit The FDA reported that they have found traces of unexpected impurities in certain batches of Losartan.  The impurity that has been detected is N-Methylnitrosobutyric acid or NMBA.  The company is only recalling batches of Losartan that contain more than the acceptable daily intake levels of NMBA set by the FDA. Losartan is an…

Read More